Dr. Sudipta Bhattacharyya is an Associate professor in the Department of Bioscience and Bioengineering at the Indian Institute of Technology Jodhpur. Dr. Bhattacharyya’s research is focused on unravelling the molecular intricacies of host-pathogen interactions and drug resistance.

Dr. Bhattacharyya has completed his B.Sc in Microbiology (Honours) from Calcutta University, followed by an M.Sc in Microbiology and Microbial Technology from Kalyani University. He has earned Ph.D. in Biochemistry and Structural Biology from Indian Institute of Technology Kharagpur. After completion of his PhD degree, Dr. Bhattacharyya completed his post-doctoral research tenures in Colorado State University, USA, University of Texas, USA and University of Melbourne, Australia. During his PhD and post-doctoral tenures, he has been extensively employed the state-of-the-art tools and techniques of Structural Biology, Enzyme Chemistry and Drug Designing. His postdoctoral research for the first time, excavated the ancestral origin of the modern nucleosome, which is the fundamental repeating unit of eukaryotic chromosomes. Moreover, his postdoctoral research works also shed light on the molecular basis of prokaryotic non-homologus end joining based dsDNA repair mechanism and the novel molecular conformation of HIV-I surface glycoprotein during cell entry and antibody dependent cellular cytotoxicity.  

At IIT Jodhpur, Dr. Bhattacharyya’s research group is principally engaged in structure-guided rational drug discovery against the dreaded ESKAPE pathogens, focusing on natural products and leveraging pharmacophore identification for the rational discovery of therapeutic leads. With a prolific academic career, Dr. Bhattacharyya has so far published more than 35 research papers in peer-reviewed international journals including the top tier journals in the field like Science, Cell Host & Microbe, PNAS etc., contributed more than 35 Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB) -based publications, and applied for 4 Indian patents. His contributions to the scientific community extend beyond research as an active member of the American Chemical Society, the Royal Society of Biology, CCP4 Bulletin Board and Phenix Bulletin Board. He is committed to foster innovation in structure guided drug discovery by inspiring the next generation of researchers in the field.